Almatica
1 products tracked · names used in filings: Almatica
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 27 Feb 2026🇺🇸 FDA approval
FDA approves Duloxetine Hydrochloride (duloxetine hydrochloride): new formulation or manufacturer
Almatica; NDA219131; New formulation or manufacturer; capsule, delayed rel pellets · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Duloxetine Hydrochloride duloxetine hydrochloride | Approved | 2026-02-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.